Form 4: Inspire Medical Systems CEO Transfers Shares and Options in Estate Planning Move

CEO Timothy P. Herbert transferred shares and options indirectly held through an LLC as part of estate planning transactions, ceasing to be the beneficial owner of those securities.

Summary

• Inspire Medical Systems CEO Timothy P. Herbert filed a Form 4 detailing changes in his beneficial ownership of company stock and options.
• On December 20, 2024, Herbert transferred 52.5% of the membership units of TPH 2022 LLC, an entity through which he indirectly held shares and options, as part of estate planning transactions.
• As a result of these transactions, Herbert is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report these holdings.
• The transactions involved common stock, as well as stock options with exercise prices of $42.15, $71, $194.82, and $227.53.
• Herbert also directly holds 9,690 shares of common stock and various stock options.
• Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust are also reported.
• The form also notes that Herbert is no longer considered the beneficial owner of securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust.
• Bryan Phillips, Attorney-in-Fact, signed the form on December 23, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing transactions by an insider. It doesn't inherently convey positive or negative sentiment regarding the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates estate planning activities by the CEO, which is a personal matter and doesn't necessarily reflect on the company's operational performance.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The transactions reported are related to estate planning, which is a common reason for such filings among executives at companies like Medtronic, Boston Scientific, and ResMed.

Stakeholder Impact

• The transactions do not appear to have a direct impact on stakeholders, as they relate to personal estate planning.

Key Dates